Pluripotent stem cells for drug development and therapy: bioprocess development challenges

被引：0
|
作者：
Alves, Paula M. [1 ]
机构：
[1] IBET, ITQB, Oeiras, Portugal
来源：
ANNALS OF MEDICINE | 2019年 / 51卷
关键词：
D O I：
10.1080/07853890.2018.1560031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] PLURIPOTENT STEM CELLS FOR DRUG DEVELOPMENT AND THERAPY: BIOPROCESS DEVELOPMENT CHALLENGES
    Alves, Paula M.
    TISSUE ENGINEERING PART A, 2022, 28 : S254 - S255
  • [2] The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
    Thorrez, Lieven
    Sampaolesi, Maurilio
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (30) : 3258 - 3270
  • [3] Development of pluripotent stem cells for vascular therapy
    Volz, Katharina S.
    Miljan, Erik
    Khoo, Amanda
    Cooke, John P.
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 288 - 296
  • [4] Integrating Human Pluripotent Stem Cells into Drug Development
    Engle, Sandra J.
    Puppala, Dinesh
    CELL STEM CELL, 2013, 12 (06) : 669 - 677
  • [5] The Use of Induced Pluripotent Stem Cells in Drug Development
    Inoue, H.
    Yamanaka, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 655 - 661
  • [6] Ethnically diverse pluripotent stem cells for drug development
    Fakunle, Eyitayo S.
    Loring, Jeanne F.
    TRENDS IN MOLECULAR MEDICINE, 2012, 18 (12) : 709 - 716
  • [7] The development of pluripotent stem cells
    Gokhale, Paul J.
    Andrews, Peter W.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2012, 22 (05) : 403 - 408
  • [8] The Challenges for Drug Development: Cytokines, Genes, and Stem Cells
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2012, 9 (04) : 231 - 232
  • [9] ASSAY DEVELOPMENT AND CELL CHARACTERIZATION CHALLENGES OF HUMAN INDUCED PLURIPOTENT STEM CELLS FOR CELL THERAPY APPLICATIONS
    Baghbaderani, B. Ahmadian
    Syama, A.
    Sivapatham, R.
    Pei, Y.
    Mukherjee, O.
    Tian, X.
    Tran, H.
    Menendez, L.
    Fellner, T.
    Zeng, X.
    Rao, M.
    CYTOTHERAPY, 2017, 19 (05) : S91 - S91
  • [10] Furthering disease investigation and drug development through pluripotent stem cells
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (06) : 647 - 647
12345